Department of Urology, University of Patras, Patras, Greece.
Department of Urology, University of Patras, Patras, Greece.
Eur Urol Focus. 2017 Dec;3(6):554-566. doi: 10.1016/j.euf.2017.04.006. Epub 2017 Apr 26.
The management of large ureteric stones represents a technical and clinical challenge.
To investigate the safety and efficacy of minimally invasive surgical ureterolithotomy (MISU) in comparison with ureteroscopic lithotripsy (URS) for the treatment of large ureteric stones.
The Preferred Reporting Items for Systematic Review and Meta-analyses (PRISMA) guidelines were followed for the conduction of the study, which was registered in the PROSPERO database. Search string was "(laparoscop* OR retroperito* OR robot*) AND ureterolitho*"; database scope included PubMed, SCOPUS, Cochrane, and EMBASE. Primary end points were the stone-free (SFR) and complications rates. Secondary end points included operative time and hospital stay. Subgroup analyses were performed for stones 1-2 and >2cm, as well as different lithotripters and ureteroscopes. Meta-analysis and forest-plot diagrams were performed with the RevMan 5.3.5 software.
After screening 673 publications, seven randomized controlled trials were eligible to be included in the meta-analysis. A total of 778 patients were pooled after the elimination of the dropouts. No robotic cohorts were found. Only upper ureteral stones were treated in the included studies. The SFR at discharge and 3 mo was higher with MISU with odds ratios of 6.30 (95% confidence interval [CI]: 3.05, 13.01; I=0%) and 5.34 (95% CI: 2.41, 8.81; I=0%), respectively. The most common complications for MISU and URS were conversion to open surgery and stone migration to the renal pelvis, respectively. Favorable results in terms of operative time were observed in the case of URS with a mean difference of 29.5min (95% CI: 14.74, 44.26; I=98%). Hospitalization time was favorable in the case of URS with a mean difference of 2.08 days (95% CI: 0.96, 3.20; I=99%).
This meta-analysis showed a significantly higher SFR at discharge and 3 mo for MISU in comparison with URS when upper ureteral stones were treated. Operative and hospitalization time favored URS over MISU.
The current study investigated the literature on the minimally invasive management of large ureteric stones. The available evidence shows that both ureteroscopic lithotripsy and minimally invasive surgical ureterolithotomy could be considered for the treatment of these stones with similar results. The selection of the approach should be based on the advantages and disadvantages of each technique.
处理大的输尿管结石是一项具有挑战性的技术和临床难题。
研究微创输尿管切开取石术(MISU)与输尿管镜碎石术(URS)治疗大的输尿管结石的安全性和有效性。
研究遵循系统评价和荟萃分析的首选报告项目(PRISMA)指南,并在 PROSPERO 数据库中进行了注册。搜索词为“laparoscop* OR retroperito* OR robot*”AND“ureterolitho*”;数据库范围包括 PubMed、SCOPUS、Cochrane 和 EMBASE。主要终点是结石清除率(SFR)和并发症发生率。次要终点包括手术时间和住院时间。对 1-2cm 和>2cm 的结石、不同的碎石器和输尿管镜进行了亚组分析。使用 RevMan 5.3.5 软件进行荟萃分析和森林图绘制。
在筛选了 673 篇文献后,有 7 项随机对照试验符合纳入荟萃分析的条件。在排除了脱落的患者后,共有 778 名患者被纳入汇总分析。未发现机器人队列。纳入的研究仅治疗上输尿管结石。MISU 的出院和 3 个月时的 SFR 更高,优势比分别为 6.30(95%置信区间[CI]:3.05,13.01;I=0%)和 5.34(95%CI:2.41,8.81;I=0%)。MISU 和 URS 最常见的并发症分别是转为开放性手术和结石迁移到肾盂。URS 的手术时间更有利,平均差异为 29.5min(95%CI:14.74,44.26;I=98%)。URS 的住院时间更有利,平均差异为 2.08 天(95%CI:0.96,3.20;I=99%)。
本荟萃分析显示,在上输尿管结石的治疗中,与 URS 相比,MISU 的出院和 3 个月时的 SFR 明显更高。手术和住院时间方面,URS 优于 MISU。
目前的研究调查了文献中大的输尿管结石的微创治疗。现有证据表明,输尿管镜碎石术和微创输尿管切开取石术都可以考虑用于治疗这些结石,结果相似。治疗方法的选择应基于每种技术的优缺点。